ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28

Nature

Volumn 397, Issue 6716, 1999, Pages 263-266

  Hutloff, Andreas ^a   Dittrich, Anna M ^a   Beier, Katja C ^a   Eljaschewitsch, Barbara ^a   Kraft, Regine ^b   Anagnostopoulos, Ionnis ^c   Kroczek, Richard A ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR;

ANTIBODY PRODUCING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL INTERACTION; CELLULAR IMMUNITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL COMMUNICATION; CELL LINE; CLONING, MOLECULAR; GERMINAL CENTER; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES;

EID: 0033590502     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/16717     Document Type: Article

References (31)

1. Hara, T., Fu, S. M. & Hansen, J. A. Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen). J. Exp. Med. 161, 1513-1524 (1985).
2. Shahinian, A. et al. Differential T cell costimulalory requirements in CD28-deficient mice. Science 261, 609-612 (1993).
3. Lucas, P. J., Negishi, I., Nakayama, K., Fields, L. E. & Loh, D. Y. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 154, 5757-5768 (1995).
4. Lenschow, D. J., Walunas, T. L. & Bluestone, J. A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233-258 (1996).
5. Chambers, C. A. & Allison, J. P. Co-stimulation in T cell responses. Curr. Opin. Immunol. 9, 396-404 (1997).
6. Walunas, T. L. et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-413 (1994).
7. Tivol, E. et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547 (1995).
8. Waterhouse, P. et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985-988 (1995).
9. Thompson, C. B. & Allison, J. P. The emerging role of CTLA-4 as an immune attenuator. Immunity 7, 445-450 (1997).
10. Brunet, J. F. et al. A new member of the immunoglobulin superfamily - CTLA-4. Nature 328, 267-270 (1987).
11. Peach, R. J. et al. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. J. Exp. Med. 180, 2049-2058 (1994).
12. Truneh, A. et al. Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis. Mol. Immunol. 33, 321-334 (1996).
13. Nunes, J. et al. CD28 mAbs with distinct binding properties differ in their ability to induce T cell activation: analysis of early and late activation events. Int. Immunol. 5, 311-315 (1993).
14. Thompson, C. B. et al. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl Acad. Sci. USA 86, 1333-1337 (1989).
15. Kroczek, R. A. et al. Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper IgM (HIGM1)". Immunol. Rev. 138, 39-59 (1994).
16. MacLennan, I. C. Germinal centers. Annu. Rev. Immunol. 12, 117-139 (1994).
17. Tsiagbe, V. K., Inghirami, G. & Thorbecke, G. J. The physiology of germinal centers. Crit. Rev. Immunol. 16, 381-421 (1996).
18. Krummel, M. F. & Allison, J. P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183, 2533-2540 (1996).
19. Walunas, T. L., Bakker, C. Y. & Bluestone, J. A. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183, 2541-2550 (1996).
20. Nakanishi, K. et al. Both interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factors in IgM synthesis. J. Exp. Med. 160, 1605-1621 (1984).
21. Jung, L. K., Hara, T. & Fu, S. M. Detection and functional studies of p60-65 (Tac antigen) on activated human B cells. J. Exp. Med. 160, 1597-1602 (1984).
22. Rousset, F. et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl Acad. Sci. USA 89, 1890-1893 (1992).
23. Kindler, V. & Zubler, R. H. Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3. J. Immunol. 159, 2085-2090 (1997).
24. Choe, J. & Choi, Y. S. IL-10 interrupts memory B cell expansion in the germinal center by inducing differentiation into plasma cells. Eur. J. Immunol 28, 508-515 (1998).
25. Schneider, C., Newman, R. A., Sutherland, D. R., Asser, U. & Greaves, M. F. A one-step purification of membrane proteins using a high efficiency immunomatrix. J. Biol. Chem. 257, 10766-10769 (1982).
26. Rosenfeld, J., Capdevielle, J., Guillemot, J. C. & Ferrara, P. In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal. Biochem. 203, 173-179 (1992).
27. Jacobs, K. A. et al. The thermal stability of oligonucleotide duplexes is sequence independent in tetraalkylammonium salt solutions: application to identifying recombinant DNA clones. Nucleic Acids Res. 16, 4637-4650 (1980).
28. Aruffo, A. & Seed, B. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. Natl Acad. Sci. USA 84, 8573-8577 (1987).
29. Williams, A. F. & Barclay, A. N. The immunoglobulin superfamily - domains for cell surface recognition. Annu. Rev. Immunol. 6, 381-405 (1988).
30. Cordell, J. L. et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 32, 219-229 (1984).
31. Prediction of transmembrane helices in proteins [online] (cited 01 Dec. 98)(www.cbs.dtu.dk/services/ TMHMM-1.0/) (1998).